R&D Podcasts | pharmaphorum

Podcasts

R&D

black lady smiling and looking at laptop

Working together to innovate on pragmatic clinical trials, w...

In today’s episode, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio management at TransCelerate Biopharma.

R&D

Biotech’s biggest challenge isn’t scientific, but political ...

We speak to James Roosevelt Jr, a longtime healthcare leader, former associate commissioner of social security for retirement policy & grandson of FDR

R&D

pharmaphorum podcast Episode 209a, Gene Mack

Allosteric small molecule therapies in PD, with Gene Mack

pharmaphorum looks back to a conversation with Gain Therapeutics' CEO Gene Mack earlier in the year, on research in the Parkinson's disease space.

R&D

pharmaphorum podcast Episode 207a, Brandon Pence

The importance of being disruption ready, with Brandon Pence

Brandon Pence, recently appointed President and COO of Fujifilm Biosciences, discusses the cell culture media industry and being disruption ready.

R&D

pharmaphorum podcast Episode 203a: Ali Pashazadeh, Treehill

The glimmer of opportunity behind the storm: Ali Pashazadeh ...

Former surgeon and investment banker Ali Pashazadeh, CEO of Treehill, discusses the current ‘perfect storm’ in biotech.

R&D

pharmaphorum podcast Episode 202a - Hilary Eaton, Profluent

Changing the drug development treatment paradigm: Hilary Eat...

Hilary Eaton, a rare disease advocate and chief business officer at Profluent, discusses AI-first protein design and accelerating biomedicine.